Cargando…

Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study

Metabolic syndrome (MetS), defined as the coexistence of interrelated cardiometabolic risk factors, is limited by ignoring the severity of the disease and individuals with a pre-metabolic state. We aimed to develop the first age- and sex-specific continuous MetS severity score in the adult populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Honarvar, Mohammadjavad, Masoumi, Safdar, Mehran, Ladan, Khalili, Davood, Amouzegar, Atieh, Azizi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170075/
https://www.ncbi.nlm.nih.gov/pubmed/37160960
http://dx.doi.org/10.1038/s41598-023-33294-w
_version_ 1785039162687094784
author Honarvar, Mohammadjavad
Masoumi, Safdar
Mehran, Ladan
Khalili, Davood
Amouzegar, Atieh
Azizi, Fereidoun
author_facet Honarvar, Mohammadjavad
Masoumi, Safdar
Mehran, Ladan
Khalili, Davood
Amouzegar, Atieh
Azizi, Fereidoun
author_sort Honarvar, Mohammadjavad
collection PubMed
description Metabolic syndrome (MetS), defined as the coexistence of interrelated cardiometabolic risk factors, is limited by ignoring the severity of the disease and individuals with a pre-metabolic state. We aimed to develop the first age- and sex-specific continuous MetS severity score in the adult population using confirmatory factor analysis (CFA) based on the MetS components in the Middle East. Using data from the population-based Tehran Lipid and Glucose Study (TLGS) I and II datasets, we conducted CFA of the single factor MetS on 8933 adults (20–60 years old) totally, and in age and sex subgroups. We allowed for different factor loadings across the subgroups to formulate age- and sex-specific continuous MetS severity score equations. Thereafter, we validated these equations in the dataset of TLGS III participants. Triglyceride had the highest factor loading across age and sex subgroups, indicating the most correlation with MetS. Except for women aged 40–60 years, waist circumference was the second most significant factor contributing to MetS. Systolic blood pressure was more closely related to MetS in women than in men. Systolic blood pressure and fasting plasma glucose had the weakest correlation with MetS among the 40–60 age group. Moreover, as women age, the contribution of fasting plasma glucose to MetS tended to decline, while it remained relatively constant in men. The resulting MetS severity score was correlated with age and homeostasis model assessment of insulin resistance. Furthermore, the continuous MetS severity score well predicted the traditional MetS according to receiver operating characteristic analysis in the validation dataset. The age- and sex-specific continuous MetS severity score for the West Asian adult population provides a tangible quantitative measure of MetS enabling clinicians to screen and monitor the individuals at risk and assess their metabolic trends.
format Online
Article
Text
id pubmed-10170075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101700752023-05-11 Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study Honarvar, Mohammadjavad Masoumi, Safdar Mehran, Ladan Khalili, Davood Amouzegar, Atieh Azizi, Fereidoun Sci Rep Article Metabolic syndrome (MetS), defined as the coexistence of interrelated cardiometabolic risk factors, is limited by ignoring the severity of the disease and individuals with a pre-metabolic state. We aimed to develop the first age- and sex-specific continuous MetS severity score in the adult population using confirmatory factor analysis (CFA) based on the MetS components in the Middle East. Using data from the population-based Tehran Lipid and Glucose Study (TLGS) I and II datasets, we conducted CFA of the single factor MetS on 8933 adults (20–60 years old) totally, and in age and sex subgroups. We allowed for different factor loadings across the subgroups to formulate age- and sex-specific continuous MetS severity score equations. Thereafter, we validated these equations in the dataset of TLGS III participants. Triglyceride had the highest factor loading across age and sex subgroups, indicating the most correlation with MetS. Except for women aged 40–60 years, waist circumference was the second most significant factor contributing to MetS. Systolic blood pressure was more closely related to MetS in women than in men. Systolic blood pressure and fasting plasma glucose had the weakest correlation with MetS among the 40–60 age group. Moreover, as women age, the contribution of fasting plasma glucose to MetS tended to decline, while it remained relatively constant in men. The resulting MetS severity score was correlated with age and homeostasis model assessment of insulin resistance. Furthermore, the continuous MetS severity score well predicted the traditional MetS according to receiver operating characteristic analysis in the validation dataset. The age- and sex-specific continuous MetS severity score for the West Asian adult population provides a tangible quantitative measure of MetS enabling clinicians to screen and monitor the individuals at risk and assess their metabolic trends. Nature Publishing Group UK 2023-05-09 /pmc/articles/PMC10170075/ /pubmed/37160960 http://dx.doi.org/10.1038/s41598-023-33294-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Honarvar, Mohammadjavad
Masoumi, Safdar
Mehran, Ladan
Khalili, Davood
Amouzegar, Atieh
Azizi, Fereidoun
Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title_full Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title_fullStr Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title_full_unstemmed Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title_short Development and validation of a continuous metabolic syndrome severity score in the Tehran Lipid and Glucose Study
title_sort development and validation of a continuous metabolic syndrome severity score in the tehran lipid and glucose study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170075/
https://www.ncbi.nlm.nih.gov/pubmed/37160960
http://dx.doi.org/10.1038/s41598-023-33294-w
work_keys_str_mv AT honarvarmohammadjavad developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy
AT masoumisafdar developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy
AT mehranladan developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy
AT khalilidavood developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy
AT amouzegaratieh developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy
AT azizifereidoun developmentandvalidationofacontinuousmetabolicsyndromeseverityscoreinthetehranlipidandglucosestudy